UFP Technologies, Inc.

NASDAQ:UFPT

Medical - Devices

Healthcare
$305.65 +4.44%

+$10.10 today

Market cap
$2.37B
Beta
1.10
P/E (TTM)
26.8
EPS (TTM)
$8.89
52W Low $173.86High $274.93

Volume 0.08M

Average 0.21M

UFPT EBITDA Margin

EBITDA as a percentage of revenue.

UFP Technologies, Inc.NASDAQ: UFPT

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin holds steady near 19.0%

EBITDA Margin was 19.0% in Q2 FY2026, down 0.2 pp from a year earlier. On a trailing-twelve-month basis it was 18.4%, down 0.8 pp year over year. Over 3 fiscal years it narrowed by 0.5 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 18.4% for the fiscal year ending Dec 2026, down from 18.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
19.0%+0.7 pp QoQ
Last fiscal yearDec 2025
18.5%-0.5 pp YoY
LTMJun 2026
18.4%-0.8 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.2 pp+0.0 pp+0.2 pp
1 year-0.5 pp-0.1 pp+0.4 pp
3 years-0.5 pp+2.1 pp+2.6 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
18.5%
Year-over-year change
-0.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How UFPT compares with its peers on the latest reported figures

  • UFPT's LTM Jun 2026 EBITDA Margin of 18.4% is the 2nd highest of the 11 companies compared; the peer median is -3.4%.
  • Its year-over-year change of -0.8 pp is the 6th highest of 11, against a peer median of -2.0 pp.
  • Over three fiscal years its change of -0.5 pp compares with a peer median of +6.3 pp.
UFPT Competitors Peer median
EBITDA Margin for UFPT and competitors
Company Period LTM level YoY 3-year change
MDTMedtronic plcLTM Jul 202627.3% +0.0 pp-0.9 pp
UFPTUFP Technologies, Inc.LTM Jun 202618.4% -0.8 pp-0.5 pp
GEHCGE HealthCare Technologies Inc.LTM Jun 202615.2% -4.0 pp+1.1 pp
CNMDCONMED CorporationLTM Mar 202612.4% -6.5 pp+10.5 pp
KIDSOrthoPediatrics Corp.LTM Mar 2026-2.7% +3.5 pp+2.1 pp
SIBNSI-BONE, Inc.LTM Mar 2026-2.9% +7.7 pp+46.2 pp
ESTAEstablishment Labs Holdings Inc.LTM Sep 2026-4.0% +21.1 pp+24.5 pp
SSIISS Innovations International, Inc.LTM Mar 2026-7.7% +82.2 pp+350.1 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026-17.6% -28.7 pp-44.6 pp
ENOVEnovis CorporationLTM Apr 2026-32.8% -10.9 pp-52.4 pp
RXSTRxSight, Inc.LTM Mar 2026-33.9% -19.3 pp+89.0 pp
Peer median (excluding UFPT) -3.4%-2.0 pp+6.3 pp

Competitors are the stored peer set for UFPT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue206.32M353.79M400.07M504.42M602.8M
Cost of Revenue155.21M263.53M287.85M357.73M432.39M
Gross Profit51.11M90.26M112.23M146.69M170.41M
Gross Margin24.8%25.5%28.1%29.1%28.3%
Research & Development00000
Selling, General & Admin29.48M45.8M50.89M62.22M77.44M
Operating Expenses29.9M34.86M54.56M65.8M78.07M
Depreciation & Amortization8.41M11.89M11.41M14.72M19.15M
EBITDA29.65M67.37M68.95M95.8M111.47M
EBITDA Margin14.4%19.0%17.2%19.0%18.5%
Operating Income21.22M55.4M57.66M80.9M92.34M
Operating Margin10.3%15.7%14.4%16.0%15.3%
Interest Income49K0000
Interest Expense39K2.76M3.65M8.06M9.8M
Other Income / Expenses(13K)(2.68M)(3.76M)(7.87M)(9.83M)
Income Before Tax21.21M52.72M53.9M73.03M82.51M
Pre-Tax Margin10.3%14.9%13.5%14.5%13.7%
Income Tax Expense5.32M10.93M8.98M14.04M14.2M
Net Income15.89M41.79M44.92M58.98M68.31M
Net Margin7.7%11.8%11.2%11.7%11.3%
EPS (Basic)2.115.525.897.698.87
EPS (Diluted)2.095.455.837.588.77
Weighted Avg Shares7.52M7.56M7.62M7.67M7.71M
Weighted Avg Shares (Diluted)7.62M7.66M7.7M7.79M7.8M

UFP Technologies, Inc.

NASDAQ:UFPT

Intrinsic Alpha fair value

Locked

Current Price

$305.65

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.